ArticleThe Journal of clinical investigation2015

Notch promotes recurrence of dormant tumor cells following HER2/neu-targeted therapy.

Daniel L Abravanel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.